WEED, INC.

BUDZ ·Healthcare, Diagnostics & Research, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2020 FY2019 FY2018 FY2017
Revenue $0 $0 $0 $0 $0 $0 $0 $0
Cost of Revenue $0 $0 $0 $0
Gross Profit $0 $0 $0 $0
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $1.1M $351.1K $394.6K $567.2K $313.9K $969.9K $1.4M $671.7K
Operating Income $-1.3M $-530.0K $-770.6K $-1.5M $-4.1M $-27.4M $-28.4M $-2.4M
Operating Margin
Interest Expense $5.1K $45.3K $117.1K $40.8K $11.7K $12.2K $13.9K
Pretax Income $-1.4M $-510.3K $-1.5M $-4.1M
Income Tax Expense $33 $399 $980 $0
Net Income $-1.4M $-510.7K $-31.6K $-1.5M $-4.1M $-27.5M $-29.3M $-3.5M
Net Margin
EPS (Basic) $0.00 $0.00 $-0.01 $-0.04 $-0.26 $-0.28 $-0.03
EPS (Diluted) $-0.01 $0.00 $0.00 $-0.04 $-0.26 $-0.28 $-0.03
Shares Outstanding (Basic) 124.1M 123.7M 122.1M 113.4M 109.3M 106.0M 100.9M
Shares Outstanding (Diluted) 135.9M 124.1M 123.7M 122.1M 113.4M 109.3M 106.0M 100.9M
Dividends Per Share
← Newer Page 1 of 2 Older →